186 related articles for article (PubMed ID: 31467367)
1. Hypercalcemia is common during Pneumocystis pneumonia in kidney transplant recipients.
Hamroun A; Lenain R; Bui Nguyen L; Chamley P; Loridant S; Neugebauer Y; Lionet A; Frimat M; Hazzan M
Sci Rep; 2019 Aug; 9(1):12508. PubMed ID: 31467367
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D metabolite-mediated hypercalcemia with suppressed parathormone concentration in Pneumocystis jiroveci pneumonia after kidney transplantation.
Hajji K; Dalle F; Harzallah A; Tanter Y; Rifle G; Mousson C
Transplant Proc; 2009 Oct; 41(8):3320-2. PubMed ID: 19857741
[TBL] [Abstract][Full Text] [Related]
3. Hypercalcemia associated with
Coche S; Cornet G; Morelle J; Labriola L; Kanaan N; Demoulin N
Acta Clin Belg; 2021 Feb; 76(1):75-78. PubMed ID: 31470765
[No Abstract] [Full Text] [Related]
4. Severe hypercalcemia preceding a diagnosis of Pneumocystis jirovecii pneumonia in a liver transplant recipient.
Yau AA; Farouk SS
BMC Infect Dis; 2019 Aug; 19(1):739. PubMed ID: 31438872
[TBL] [Abstract][Full Text] [Related]
5. Pneumocystis jirovecii pneumonia with an atypical granulomatous response after kidney transplantation.
Ramalho J; Bacelar Marques ID; Aguirre AR; Pierrotti LC; de Paula FJ; Nahas WC; David-Neto E
Transpl Infect Dis; 2014 Apr; 16(2):315-9. PubMed ID: 24621124
[TBL] [Abstract][Full Text] [Related]
6. Hypercalcemia and pneumocystis Pneumonia after kidney transplantation: report of an exceptional case and literature review.
Chatzikyrkou C; Clajus C; Haubitz M; Hafer C
Transpl Infect Dis; 2011 Oct; 13(5):496-500. PubMed ID: 21414118
[TBL] [Abstract][Full Text] [Related]
7. Hypercalcemia as an Early Finding of Opportunistic Fungal Pneumonia in Renal Transplantation: A Case Series Report.
Giordani MC; Villamil Cortez SK; Diehl M; Barcan LA; Rosa-Diez G; Groppa SR; Schreck C; Mombelli C; Imperiali N
Transplant Proc; 2020 May; 52(4):1178-1182. PubMed ID: 32340747
[TBL] [Abstract][Full Text] [Related]
8. Clinical descriptive analysis of severe
Xie D; Xu W; You J; Yuan X; Li M; Bi X; Zhang K; Li H; Xian Y
Bioengineered; 2021 Dec; 12(1):1264-1272. PubMed ID: 33896387
[No Abstract] [Full Text] [Related]
9. Lymphopenia is associated with late onset Pneumocystis jirovecii pneumonia in solid organ transplantation.
Werbel WA; Ison MG; Angarone MP; Yang A; Stosor V
Transpl Infect Dis; 2018 Jun; 20(3):e12876. PubMed ID: 29512868
[TBL] [Abstract][Full Text] [Related]
10. Hypercalcemia in a renal transplant recipient suffering with Pneumocystis carinii pneumonia.
Chen WC; Chang SC; Wu TH; Yang WC; Tarng DC
Am J Kidney Dis; 2002 Feb; 39(2):E8. PubMed ID: 11840399
[TBL] [Abstract][Full Text] [Related]
11. Application of metagenomic next-generation sequencing in the diagnosis and treatment guidance of Pneumocystis jirovecii pneumonia in renal transplant recipients.
Zhang F; Chen J; Huang H; Deng X; Zhang W; Zeng M; Liu R; Dai L; Wan Q
Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1933-1942. PubMed ID: 33880744
[TBL] [Abstract][Full Text] [Related]
12. Hypercalcemia and suppressed PTH levels in a renal transplant patient infected with Pneumocystis carinii.
Aguirre AR; Balbo BE; Ianhez LE; da Costa MC; Andrade L
Ren Fail; 2007; 29(4):513-6. PubMed ID: 17497478
[TBL] [Abstract][Full Text] [Related]
13. Single-center retrospective analysis of Pneumocystis jirovecii pneumonia in patients after deceased donor renal transplantation.
Zou J; Wang T; Qiu T; Zhou J; Chen Z; Ma X; Jin Z; Xu Y; Zhang L
Transpl Immunol; 2022 Jun; 72():101593. PubMed ID: 35367619
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and risk factors for late-onset pneumocystis jirovecii pneumonia in kidney transplantation recipients.
Zhu X; Xie M; Fan J; Geng B; Fei G; Zhou Q; Wu H; Liu X; Jiang X
Mycoses; 2024 Jan; 67(1):e13688. PubMed ID: 38214337
[TBL] [Abstract][Full Text] [Related]
15. Risk factors and outcomes of Pneumocystis pneumonia in solid organ transplant recipients: Impact of posttransplant lymphoproliferative disorder.
Yetmar ZA; Duffy D; Smith BH; Vikram HR; Brumble L; Limper AH; Beam E
Clin Transplant; 2023 Sep; 37(9):e15021. PubMed ID: 37195184
[TBL] [Abstract][Full Text] [Related]
16. Risk Evaluation and Outcome of Pneumocystis jirovecii Pneumonia in Kidney Transplant Patients.
Brakemeier S; Dürr M; Bachmann F; Schmidt D; Gaedeke J; Budde K
Transplant Proc; 2016 Nov; 48(9):2924-2930. PubMed ID: 27932109
[TBL] [Abstract][Full Text] [Related]
17. Pneumocystis jirovecii pneumonia presenting with severe, refractory hypercalcaemia in an immunosuppressed renal transplant patient: Review of the literature and novel biochemical insights.
Hong L; Witton LD; Jolly EC
Clin Med (Lond); 2024 Jan; 24(1):100011. PubMed ID: 38377731
[TBL] [Abstract][Full Text] [Related]
18. The impact of cytomegalovirus infection on clinical severity and outcomes in kidney transplant recipients with Pneumocystis jirovecii pneumonia.
Lee S; Park Y; Kim SG; Ko EJ; Chung BH; Yang CW
Microbiol Immunol; 2020 May; 64(5):356-365. PubMed ID: 31994768
[TBL] [Abstract][Full Text] [Related]
19. Pneumocystis jiroveci pneumonia in kidney and simultaneous pancreas kidney transplant recipients in the present era of routine post-transplant prophylaxis: risk factors and outcomes.
Garg N; Jorgenson M; Descourouez J; Saddler CM; Parajuli S; Astor BC; Djamali A; Mandelbrot D
BMC Nephrol; 2018 Nov; 19(1):332. PubMed ID: 30463516
[TBL] [Abstract][Full Text] [Related]
20. Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant Cohort.
Neofytos D; Hirzel C; Boely E; Lecompte T; Khanna N; Mueller NJ; Boggian K; Cusini A; Manuel O; van Delden C;
Transpl Infect Dis; 2018 Dec; 20(6):e12984. PubMed ID: 30155950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
